Canine Superpowers: The Future of Early Cancer Detection | Itamar Bitan - Co-Founder, Dognosis

Episode notes

Send us Fan Mail Dogs can detect explosives, narcotics, missing persons, and even disease. But what if their greatest superpower isn't finding things - it's sensing molecular changes inside the human body long before symptoms appear? Today we're exploring whether the canine nose may hold the key to the next generation of cancer diagnostics. Itamar Bitan is the Co-Founder of Dognosis ( ), a pioneering company working to unlock one of nature's most extraordinary sensing systems - the canine nose - and combine it with cutting-edge brain-computer interfaces and machine learning. Driven by a passion for both human health and working dogs, Itamar brings together an unusual blend of expertise spanning elite military operations, canine behavior, disease detection, and technology innovation. He spent nearly four years serving in Oketz, the Israeli Defense Forces' elite special operations K9 unit, where he worked as both a combat soldier and commander, developing deep expertise in canine training, scent detection, and high-pressure operational environments.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• The Evolution and Impact of AI and Machine Learning Across IndustriesBeyond the Screen · on Artificial intelligence79 / 100
• World's Leading Safe AI Expert: Superintelligence Will Change Everything & It's Closer Than You Think! - Dr. Craig A. KaplanFour Fs Podcast · on Artificial intelligence74 / 100
• 101: Rapid Transformation - AI, Psychedelics & Leadership with Dr Catriona WallaceHabits of Leadership · on Artificial intelligence73 / 100
• Deep Tech Gold Rush: Smart Boom or Future Bust?Venture Unlocked · on Artificial intelligence71 / 100
• From “What Is” to “What If” in ConstructionThe Power of Construction · on Artificial intelligence69 / 100
• Is It a Bubble?The Memo by Howard Marks · on Artificial intelligence68 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences